Has Sandeep Grover, MD received payments from drug or device companies?

Yes. Drug and device makers reported $71,367 in general payments to Sandeep Grover, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandeep Grover, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandeep Grover, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandeep Grover, MD

Ophthalmology · Jacksonville, FLNPI 1437121324

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $60,700 of the $71,367 with a category attached, or 85.1%. Johnson & Johnson accounts for 80.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $45,388 and has fallen 66.1% since, to $15,365 in 2025. Among ophthalmology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,367in general payments, 2019–2025

Across 78 payments — averaging $914.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$57K
Takeda Pharmaceuticals U.S.A., Inc.$13K
Amgen$455
Regeneron Healthcare Solutions, Inc.$200
AbbVie$181
Sight Sciences, Inc.$173
plus $616 from 6 others

$2,500in research payments, 2019–2025

Across 4 payments — averaging $625.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Takeda Pharmaceuticals U.S.A., Inc.$3K

What the payments were for

Consulting fees$60,70085%
Travel & lodging$8,21512%
Food & beverage$2,4123%
Gifts$390%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	55	$57,142
Takeda Pharmaceuticals U.S.A., Inc.	4	$12,600
Amgen(2 entities)	4	$455
Regeneron Healthcare Solutions, Inc.	2	$200
AbbVie	2	$181
Sight Sciences, Inc.	2	$173
Glaukos Corporation	1	$159
NEW World Medical,inc.	1	$146
Apellis Pharmaceuticals, Inc.	1	$122
Edwards Lifesciences	1	$76
Alcon	3	$74
Carl Zeiss Meditec AG	2	$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,367 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024

$64,537

Medicare patients

221

Services billed

738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	22	$1,303
Latanoprost	122	$745
Dorzolamide Hcl	19	$489
MoxifloxacinMoxifloxacin Hcl	11	$311
Brimonidine Tartrate	17	$73

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Jacksonville

Syril DorairajJacksonville$432K
Frank BowdenJacksonville$169K
David KostickJacksonville$108K
Cathleen McCabeBradenton$2M
Daniel KiernanSarasota$1.7M
David EichenbaumSt Petersburg$1.7M
Mark MilnerPalm Beach Gardens$1.2M
Neel DesaiLargo$1M
Jorge FortunPalm Beach Gardens$798K
Courtney BoveeTampa$796K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →